1. Home
  2. ACV vs GNFT Comparison

ACV vs GNFT Comparison

Compare ACV & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACV
  • GNFT
  • Stock Information
  • Founded
  • ACV 2015
  • GNFT 1999
  • Country
  • ACV United States
  • GNFT France
  • Employees
  • ACV N/A
  • GNFT N/A
  • Industry
  • ACV Finance/Investors Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACV Finance
  • GNFT Health Care
  • Exchange
  • ACV Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • ACV 229.2M
  • GNFT 214.5M
  • IPO Year
  • ACV N/A
  • GNFT 2019
  • Fundamental
  • Price
  • ACV $21.94
  • GNFT $3.93
  • Analyst Decision
  • ACV
  • GNFT Strong Buy
  • Analyst Count
  • ACV 0
  • GNFT 1
  • Target Price
  • ACV N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • ACV 38.8K
  • GNFT 3.3K
  • Earning Date
  • ACV 01-01-0001
  • GNFT 04-24-2025
  • Dividend Yield
  • ACV 9.20%
  • GNFT N/A
  • EPS Growth
  • ACV N/A
  • GNFT N/A
  • EPS
  • ACV N/A
  • GNFT 0.03
  • Revenue
  • ACV N/A
  • GNFT $73,187,701.00
  • Revenue This Year
  • ACV N/A
  • GNFT $15.98
  • Revenue Next Year
  • ACV N/A
  • GNFT N/A
  • P/E Ratio
  • ACV N/A
  • GNFT $124.79
  • Revenue Growth
  • ACV N/A
  • GNFT 105.01
  • 52 Week Low
  • ACV $16.82
  • GNFT $2.55
  • 52 Week High
  • ACV $23.74
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ACV 54.70
  • GNFT 42.09
  • Support Level
  • ACV $21.74
  • GNFT $4.03
  • Resistance Level
  • ACV $22.05
  • GNFT $4.61
  • Average True Range (ATR)
  • ACV 0.24
  • GNFT 0.12
  • MACD
  • ACV -0.11
  • GNFT -0.05
  • Stochastic Oscillator
  • ACV 21.11
  • GNFT 0.00

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: